Long-Term Care medicines formularies: any reasons for pharmacists’ concern?

Detalhes bibliográficos
Autor(a) principal: Rafael Gonçalves, João
Data de Publicação: 2023
Outros Autores: Avancini Sole, Giordano, Miguel Cavaco, Afonso
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/225574
Resumo: This study aimed to characterize and compare medicines formularies (MFs) used in Long-Term Care (LTC) facilities in Portugal, and to identify the prevalence of Potentially Inappropriate Medicines (PIMs). A systematic contact with LTC facilities was undertaken in December 2021. MFs were systematized according to the Anatomical Therapeutical Chemical classification system (ATC), followed by descriptive content analysis. A structured comparison between MFs developed by public organizations and private LTC facilities was performed. After duplicate removal and exclusion of medicines not for systemic use, two explicit criteria - the Algorithm of medication review in frail older people and the EU(7)-PIM list - were employed for PIMs identification. Five MFs were obtained and assessed. The three MFs developed by private institutions covered 23% of the national LTC facilities and approximately 34% of the national total of beds. Heterogeneity was particularly high for the Alimentary tract and metabolism, Blood and blood-forming organs, Musculoskeletal system, and Respiratory system ATC groups. A PIM prevalence of 29,4% was identified. Medicines distribution between the MFs suggests the need to develop national guidelines towards harmonizing medicines usage in LTC. The prevalence of PIMs found highlights the importance of a particular optimized use of this health technology in aged sub-populations.
id USP-31_0b1bbab5ef6e992973b7cd934723c82d
oai_identifier_str oai:revistas.usp.br:article/225574
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Long-Term Care medicines formularies: any reasons for pharmacists’ concern?Medicines formularies;Long-Term Care;Aged;Pharmacists;Pharmacy & Therapeutics CommitteeThis study aimed to characterize and compare medicines formularies (MFs) used in Long-Term Care (LTC) facilities in Portugal, and to identify the prevalence of Potentially Inappropriate Medicines (PIMs). A systematic contact with LTC facilities was undertaken in December 2021. MFs were systematized according to the Anatomical Therapeutical Chemical classification system (ATC), followed by descriptive content analysis. A structured comparison between MFs developed by public organizations and private LTC facilities was performed. After duplicate removal and exclusion of medicines not for systemic use, two explicit criteria - the Algorithm of medication review in frail older people and the EU(7)-PIM list - were employed for PIMs identification. Five MFs were obtained and assessed. The three MFs developed by private institutions covered 23% of the national LTC facilities and approximately 34% of the national total of beds. Heterogeneity was particularly high for the Alimentary tract and metabolism, Blood and blood-forming organs, Musculoskeletal system, and Respiratory system ATC groups. A PIM prevalence of 29,4% was identified. Medicines distribution between the MFs suggests the need to develop national guidelines towards harmonizing medicines usage in LTC. The prevalence of PIMs found highlights the importance of a particular optimized use of this health technology in aged sub-populations.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-08-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://www.revistas.usp.br/bjps/article/view/22557410.1590/Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); 12Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); 12Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); 122175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/225574/204884Copyright (c) 2024 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Rafael Gonçalves, JoãoAvancini Sole, GiordanoMiguel Cavaco, Afonso2024-05-23T17:59:53Zoai:revistas.usp.br:article/225574Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2024-05-23T17:59:53Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
title Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
spellingShingle Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
Rafael Gonçalves, João
Medicines formularies;
Long-Term Care;
Aged;
Pharmacists;
Pharmacy & Therapeutics Committee
title_short Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
title_full Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
title_fullStr Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
title_full_unstemmed Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
title_sort Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
author Rafael Gonçalves, João
author_facet Rafael Gonçalves, João
Avancini Sole, Giordano
Miguel Cavaco, Afonso
author_role author
author2 Avancini Sole, Giordano
Miguel Cavaco, Afonso
author2_role author
author
dc.contributor.author.fl_str_mv Rafael Gonçalves, João
Avancini Sole, Giordano
Miguel Cavaco, Afonso
dc.subject.por.fl_str_mv Medicines formularies;
Long-Term Care;
Aged;
Pharmacists;
Pharmacy & Therapeutics Committee
topic Medicines formularies;
Long-Term Care;
Aged;
Pharmacists;
Pharmacy & Therapeutics Committee
description This study aimed to characterize and compare medicines formularies (MFs) used in Long-Term Care (LTC) facilities in Portugal, and to identify the prevalence of Potentially Inappropriate Medicines (PIMs). A systematic contact with LTC facilities was undertaken in December 2021. MFs were systematized according to the Anatomical Therapeutical Chemical classification system (ATC), followed by descriptive content analysis. A structured comparison between MFs developed by public organizations and private LTC facilities was performed. After duplicate removal and exclusion of medicines not for systemic use, two explicit criteria - the Algorithm of medication review in frail older people and the EU(7)-PIM list - were employed for PIMs identification. Five MFs were obtained and assessed. The three MFs developed by private institutions covered 23% of the national LTC facilities and approximately 34% of the national total of beds. Heterogeneity was particularly high for the Alimentary tract and metabolism, Blood and blood-forming organs, Musculoskeletal system, and Respiratory system ATC groups. A PIM prevalence of 29,4% was identified. Medicines distribution between the MFs suggests the need to develop national guidelines towards harmonizing medicines usage in LTC. The prevalence of PIMs found highlights the importance of a particular optimized use of this health technology in aged sub-populations.
publishDate 2023
dc.date.none.fl_str_mv 2023-08-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/225574
10.1590/
url https://www.revistas.usp.br/bjps/article/view/225574
identifier_str_mv 10.1590/
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/225574/204884
dc.rights.driver.fl_str_mv Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); 12
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); 12
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); 12
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918327664640